Mark Brooke hopes the program will signal a new era of hope for lung cancer patients. (ABC News: Lucas Hill)The screening program will offer a bulk-billed low-dose CT scan for the 930,000 people ...

Get Instant Summarized Text (Gist) A lipid nanoparticle system was developed to deliver DNase I and Sivelestat directly to lung neutrophils in a COVID-19 mouse model.

Information about lung cancer symptoms and treatments. Explore the latest medical research on cancers including experimental treatments. Skip to main content. Your source for the latest research news.

Results from a Phase III clinical trial published in the New England Journal of Medicine, show that patients with lung cancer who received an immunotherapy drug, nivolumab, along with standard ...

Researchers investigate the cause of lung damage in autoimmune diseases by Jan Grabowski, Zentrum für Experimentelle und Klinische Infektionsforschung ...

Sanofi’s shares fell following mixed results of its experimental drug for a deadly lung condition. Itepekimab, a medicine that is being jointly developed by Sanofi and Regeneron, is being tested ...

Radiation therapy is a precise, targeted treatment for lung cancer that can be used at every stage of the disease, according to Dr. Julianna Bronk during her presentation at the CURE Educated Patient® ...

Tarlatamab, a bispecific delta-like ligand 3–directed T-cell engager immunotherapy, received accelerated approval for the treatment of patients with previously treated small-cell lung cancer.

The U.S. Food and Drug Administration (FDA) has accepted and granted priority review to a new drug application (NDA) for the investigational compound sevabertinib (BAY 2927088), in adult patients with ...

Neoadjuvant nivolumab plus chemotherapy significantly improved pathological complete response and event-free survival in patients with resectable non–small-cell lung cancer (NSCLC) in a phase 3 ...